To clarify whether lidocaine attenuates cSCC progression and represses cisplatin resistance by regulating the miR-30c/SIRT1 pathway, A431 cells were treated with different lidocaine concentrations for different times. The gene discussed is SIRT1; the disease is skin squamous cell carcinoma.